Miteri Development Bank Limited
MDB
$390.75
+6.71%
MongoDB, Inc. is a document-oriented database software vendor that sells its flagship platform through two primary channels: the fully managed MongoDB Atlas cloud service and the self-managed MongoDB Enterprise Advanced offering, supplemented by professional services, serving enterprises that need flexible, developer-friendly data infrastructure. The company is a category leader in the NoSQL database market, with a developer-led, bottom-up adoption model that has driven over 500 million downloads of its free Community Server and positioned it as a platform company rather than a point solution. The current investor narrative is dominated by the abrupt departure of the CEO, which triggered an 18.5% single-day selloff in late September and reframed the debate around leadership continuity and execution risk, even as the underlying business delivered a strong quarter with 30.5% revenue growth and a swing to GAAP profitability. Bulls argue the selloff is an overreaction given an experienced board and no immediate competitive threat, while bears point to decelerating relative performance, a stretched valuation, and the question of whether Atlas consumption growth can sustain its pace without a permanent chief executive.…
MDB
Miteri Development Bank Limited
$390.75
Related headlines
Investment Opinion: Should I buy MDB Today?
Rating: Buy. The core thesis is that MongoDB's accelerating revenue growth (30.5% YoY), decisive swing to GAAP profitability, and fortress balance sheet are intact, and the CEO-departure selloff has created an attractive entry point. The analyst consensus of 'buy' (mean rating 1.65) with an average target of $449.74 implies 33.2% upside from $337.57, anchoring the bullish view. Supporting evidence is strong: revenue growth reaccelerated to 30.5% from 27.8% in the prior quarter, gross margin expanded to 73.8% from 71.0%, operating income turned positive at $28.4M, and TTM free cash flow reached $667.3M. The P/S of 12.25x is near the low end of its multi-year band (down from 101.8x in Q4 2022), and EV/sales of 9.76x is moderate given the $1.01B net cash position. However, the forward PE of 43x and PEG of 8.59 leave little room for execution missteps. The biggest risks are the CEO vacuum, potential deceleration in Atlas consumption growth, and multiple compression if growth slows. This Buy would upgrade to Strong Buy if a permanent CEO is named with a strong track record and Atlas growth holds above 30%, or downgrade to Hold if revenue growth decelerates below 25% or the CEO search drags beyond two quarters. Valuation verdict: fairly valued to slightly undervalued relative to its own history, but at a premium to the broader software sector.
Sign up to view all
MDB 12-Month Price Forecast
The forward-looking view is bullish with medium confidence. MongoDB's fundamental momentum is strong—revenue growth reaccelerated to 30.5%, profitability inflected decisively, and the balance sheet is fortress-like with $1.01B cash and $667.3M TTM FCF. The CEO departure has created a sentiment-driven selloff that appears overdone given the experienced board and no immediate competitive threat. However, the stretched forward PE of 43x and PEG of 8.59 mean the stock is not cheap, and the leadership vacuum adds uncertainty. I would upgrade to high confidence if a permanent CEO is named with a strong track record and Atlas growth holds above 30%, and downgrade to neutral if revenue growth decelerates below 25% or the CEO search drags beyond two quarters.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Miteri Development Bank Limited's 12-month outlook, with a consensus price target around $449.74 and implied upside of +15.1% versus the current price.
Average Target
$449.74
0 analysts
Implied Upside
+15.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$273 - $565
Analyst target range
Coverage is broad and bullish: 36 analysts cover MongoDB with a consensus recommendation of "buy" (mean rating 1.65 on a 1-to-5 scale where 1 is strong buy), and the average target price of $449.74 implies roughly +33.2% upside from the current $337.57. The consensus leans clearly bullish, and the recent institutional ratings show stability rather than deterioration, with Evercore ISI, BMO, RBC, and Citizens all maintaining Outperform and Needham, Guggenheim, Stifel, and DA Davidson maintaining Buy as of late September, while Stephens and Macquarie stayed Neutral. The target range is wide, from a low of $272.64 (about -19.2% downside) to a high of $565.00 (about +67.4% upside), a spread of more than 2x that signals meaningful disagreement about the CEO transition and growth durability. The high target assumes multiple expansion and sustained 30%+ growth with margin leverage, while the low target prices in execution disruption from the leadership vacuum and competitive pressure; the tight clustering of ratings around Buy/Outperform despite the selloff suggests analysts view the drop as an overreaction, but the wide target dispersion means conviction is uneven and volatility is likely to persist until a permanent CEO is named.
Drowning in data?
Find the real signal!
Bulls vs Bears: MDB Investment Factors
The bull case rests on accelerating revenue growth (30.5% YoY), a decisive swing to GAAP profitability, a fortress balance sheet with $1.01B cash and $667.3M TTM FCF, and a valuation (12.25x P/S) near multi-year lows. The bear case centers on the CEO departure, severe relative underperformance (-27.46% vs. SPY YTD), a stretched forward PE of 43x with a PEG of 8.59, and high volatility (beta 1.748). On balance, the bull evidence is stronger: the fundamental trajectory is improving, analyst consensus remains 'buy' with 33.2% upside, and the selloff appears sentiment-driven rather than fundamental. The single most important tension is whether Atlas consumption growth can sustain its 30%+ pace without a permanent CEO—resolution of this leadership question is the key catalyst that would most change the thesis.
Bullish
- Revenue growth reaccelerated to 30.5%: Q2 FY2027 revenue of $771.8M grew 30.5% YoY, up from 27.8% in Q1 ($687.6M) and 26.5% in Q4 ($695.1M), showing acceleration rather than deceleration. Atlas contributed $565.9M (73% of revenue), confirming the consumption model is scaling.
- Decisive swing to GAAP profitability: Net income turned positive at $40.9M (5.3% margin) versus a $47.0M loss a year ago, and operating income reached $28.4M (3.7% margin) from -$65.3M. Gross margin expanded to 73.8% from 71.0%, demonstrating operating leverage.
- Fortress balance sheet with strong FCF: Debt-to-equity is just 0.011, current ratio is 4.65, and cash stands at $1.01B. TTM free cash flow of $667.3M and quarterly FCF of $139.4M against only $2.5M capex show the business is self-funding and can invest through cycles.
- Analyst consensus remains bullish: 36 analysts rate MDB a 'buy' with a mean rating of 1.65 and an average target of $449.74, implying 33.2% upside from $337.57. The high target of $565.00 (+67.4%) reflects conviction in sustained 30%+ growth and margin expansion.
Bearish
- CEO departure creates leadership vacuum: The abrupt CEO departure triggered an 18.5% single-day selloff on September 28, and the stock remains 20.3% below its September 25 close of $410.44. The lack of a permanent chief executive introduces execution risk and uncertainty around strategic direction.
- Severe relative underperformance: MDB is down 15.53% YTD versus SPY's +11.93% (relative strength -27.46%), and down 10.30% over the past month versus SPY's +1.22% (relative strength -11.52%). The -7.89% single-day drop on October 16 confirms selling pressure remains intense.
- Stretched valuation on forward earnings: Forward PE of 43.02x on consensus EPS of $13.57 and a PEG ratio of 8.59 signal the market is paying heavily for growth. Price-to-free-cash-flow of 59.7x leaves little room for execution missteps.
- High volatility amplifies downside: Beta of 1.748 means the stock is ~75% more volatile than the market, and the max drawdown of -48.72% over the period underscores the risk. A breakdown below the $334 support (September 28 gap-down area) could open a retest of $300.
MDB Technical Analysis
MongoDB is in a recovery trend that has stalled badly: the stock is up 7.39% over the past year but sits at $337.57, which is roughly 47.2% of its 52-week range of $215.68 to $473.10, meaning it has given back more than half of its annual advance and is trading in the lower-middle of its range rather than near highs. The 28.17% six-month gain shows the recovery was real, but the failure to hold the August peak near $472 leaves the stock in a corrective phase within a broader uptrend. Short-term momentum has deteriorated sharply: the stock is down 10.30% over the past month versus a 1.22% gain for SPY, a relative strength of -11.52%, and down 15.53% year-to-date against SPY's +11.93% (relative strength -27.46%). The 3-month change of +8.08% still beats SPY's +2.69% (relative strength +5.39%), so the divergence is concentrated in the last several weeks and looks like a sentiment-driven pullback rather than a full trend reversal, though the -7.89% single-day drop on October 16 confirms selling pressure is intense. Key levels are clear: support sits at the 52-week low of $215.68, with intermediate support near the September 28 gap-down area around $334, while resistance is the 52-week high of $473.10 and the $400-430 zone that capped the August rally. A beta of 1.748 means the stock is roughly 75% more volatile than the market, so position sizing should account for amplified drawdowns; a max drawdown of -48.72% over the period underscores that risk, and a breakdown below $334 would open the door to a retest of the $300 area, while a reclaim of $400 would signal the correction is over.
Beta
1.75
1.75x market volatility
Max Drawdown
-48.7%
Largest decline past year
52-Week Range
$216-$473
Price range past year
Annual Return
+20.0%
Cumulative gain past year
| Period | MDB Return | S&P 500 |
|---|---|---|
| 1m | -4.1% | -0.1% |
| 3m | +30.6% | +4.7% |
| 6m | +54.1% | +8.3% |
| 1y | +20.0% | +15.2% |
| ytd | -2.2% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MDB Fundamental Analysis
Revenue growth is strong and reaccelerating: the most recent quarter (ended July 31, 2026) delivered $771.8 million in revenue, up 30.5% year-over-year, accelerating from $687.6 million in the prior quarter and $695.1 million in the quarter before that, with the year-ago comparison at $591.4 million. The Atlas-related segment generated $565.9 million, or roughly 73% of total revenue, making cloud consumption the dominant growth engine, while other subscription contributed $181.2 million and services just $24.6 million. This mix is favorable because Atlas is the higher-growth, consumption-based business, and the acceleration to 30.5% growth from the mid-20s trajectory earlier in the year supports the bull case that AI-driven application development is expanding the addressable market. Profitability has inflected decisively: net income was $40.9 million in the latest quarter (a 5.3% net margin) versus a loss of $47.0 million a year earlier, and gross margin expanded to 73.8% from 71.0%, with operating income turning positive at $28.4 million (3.7% operating margin) after a -$65.3 million operating loss in the year-ago quarter. The trailing twelve-month picture still shows a slightly negative net margin of -2.89% and operating margin of -5.56%, reflecting the earlier loss-making quarters, but the trajectory is clearly toward sustained GAAP profitability, aided by $19.7 million of interest income on a large cash balance. The balance sheet is fortress-like: debt-to-equity is just 0.011, the current ratio is 4.65, and cash stood at $1.01 billion at quarter-end, while trailing free cash flow reached $667.3 million and quarterly FCF was $139.4 million against only $2.5 million of capex. ROE of -2.41% and ROA of -0.22% remain marginally negative on a trailing basis, but the company is self-funding, bought back $100.0 million of stock in the quarter, and carries negligible financial risk; the main caveat is stock-based compensation of $148.9 million in the quarter, which is large relative to the $40.9 million net income and dilutes the quality of GAAP earnings.
Quarterly Revenue
$771773000.0B
2026-07
Revenue YoY Growth
+30.5%
YoY Comparison
Gross Margin
73.8%
Latest Quarter
Free Cash Flow
$667341000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MDB Overvalued?
Because trailing net income is marginally negative (EPS of -$0.0024, trailing PE of -421.97), the PE ratio is not meaningful, so the primary metric is the price-to-sales ratio of 12.25x, supported by the forward PE of 43.02x on consensus EPS of $13.57, which is the more relevant profitability-based anchor. The gap between the negative trailing PE and the 43x forward PE implies the market expects a sharp earnings inflection over the next twelve months, consistent with the recent swing to GAAP profitability and the 30.5% revenue growth; EV/sales of 9.76x is more moderate than the 12.25x P/S because of the net cash position. Against software-infrastructure peers, a 12.25x P/S and 43x forward PE represent a premium to the broader sector, though the exact industry average is not provided in the data; the premium is defensible given 30.5% growth and 73.8% gross margins, but the PEG ratio of 8.59 signals the market is paying heavily for that growth. Historically, MongoDB's P/S has compressed dramatically from 101.8x in Q4 2022 and 84.2x in Q1 2023 to 35.2x in Q2 2026 and now 12.25x, reflecting both multiple compression across SaaS and the company's revenue scaling; the current 12.25x sits near the low end of its multi-year band, which argues the valuation is no longer extreme relative to its own history, even if the forward PE of 43x leaves little room for execution missteps. The P/B of 10.22x and price-to-free-cash-flow of 59.7x further confirm a growth-premium valuation that depends on continued margin expansion.
PE
-422.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 165x~1136x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-993.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but manageable. The company carries negligible debt (debt-to-equity 0.011) and $1.01B in cash, but stock-based compensation of $148.9M in the latest quarter is 3.6x net income of $40.9M, meaning GAAP profitability is heavily reliant on non-cash adjustments and dilution remains a concern. Revenue concentration in Atlas ($565.9M, 73% of total) ties the company's fortunes to cloud consumption trends, and any slowdown in Atlas growth would disproportionately impact results. Additionally, the trailing twelve-month net margin is still -2.89% and operating margin -5.56%, reflecting earlier loss-making quarters; sustained profitability depends on continued margin expansion. Market and competitive risks are elevated. The stock trades at a premium valuation (12.25x P/S, 43x forward PE, PEG 8.59) that leaves little room for error, and with a beta of 1.748, it is highly sensitive to market rotations away from high-multiple software names. Competition from Oracle's consumption-based cloud database services and Meta's enterprise AI push could pressure MongoDB's pricing and win rates. The CEO departure adds governance uncertainty, and the wide analyst target range ($272.64 to $565.00) signals meaningful disagreement about growth durability. The worst-case scenario would involve a prolonged CEO search, decelerating Atlas growth below 25%, and multiple compression toward the low end of its historical range. In that scenario, the stock could retest its 52-week low of $215.68, representing a -36.1% decline from the current $337.57. A break below the $334 support level would likely accelerate selling toward the $300 area, and a deeper macro-driven selloff could push shares toward the analyst low target of $272.64 (-19.2%). Investors should position-size for a potential -35% to -40% drawdown given the stock's high volatility and max drawdown of -48.72%.
FAQ
The key risks are ranked as follows: (1) Leadership risk—the CEO departure has created a vacuum, and a prolonged search could lead to strategic drift and execution missteps, as reflected in the 18.5% single-day selloff. (2) Valuation risk—forward PE of 43x and PEG of 8.59 leave little room for error; any growth deceleration could trigger sharp multiple compression. (3) Competitive risk—Oracle's consumption-based cloud database services and Meta's enterprise AI push could pressure MongoDB's pricing and win rates. (4) Macro risk—with a beta of 1.748, the stock is highly sensitive to rotations away from high-multiple software names, and a broader market selloff could amplify downside. The max drawdown of -48.72% underscores the potential severity of these risks.
The 12-month forecast has three scenarios: Bull (30% probability, target $473.10-$565.00), Base (50% probability, target $400.00-$449.74), and Bear (20% probability, target $215.68-$272.64). The base case is most likely, assuming the CEO search concludes within two quarters, revenue growth moderates to the high-20s, and margins continue to expand. This would drive the stock toward the analyst average target of $449.74 (+33.2%). The bull case requires a permanent CEO with a strong track record and Atlas growth sustaining above 30%, while the bear case involves a prolonged CEO vacancy and decelerating growth. The key assumption behind the base case is that the CEO-departure selloff is an overreaction and fundamental momentum remains intact.
MDB's valuation is mixed depending on the metric. On a P/S basis, 12.25x is near the low end of its multi-year band (down from 101.8x in Q4 2022), suggesting the stock is fairly valued to slightly undervalued relative to its own history. However, the forward PE of 43.02x and PEG ratio of 8.59 indicate the market is still paying a premium for growth, leaving little room for execution missteps. EV/sales of 9.76x is more moderate given the $1.01B net cash position. Relative to the broader software sector, MDB trades at a premium, but this is defensible given 30.5% growth and 73.8% gross margins. The market appears to be pricing in sustained 25-30% growth and continued margin expansion; any deceleration would likely trigger multiple compression.
From a risk/reward perspective, MDB offers a favorable setup for growth-oriented investors. The stock trades at $337.57, implying 33.2% upside to the analyst average target of $449.74, with a consensus 'buy' rating from 36 analysts. The fundamental momentum is strong—revenue growth reaccelerated to 30.5%, GAAP profitability turned positive at $40.9M, and free cash flow reached $667.3M TTM. However, the biggest downside risk is the CEO vacuum, which could push the stock toward its 52-week low of $215.68 (-36.1%) if the search drags. For investors with a medium-to-long-term horizon and tolerance for volatility (beta 1.748), the risk/reward is attractive at current levels, but position sizing should account for a potential -35% drawdown.
MDB is better suited for long-term investment (minimum 2-3 years) than short-term trading. The stock's high beta (1.748) and max drawdown (-48.72%) make it unsuitable for short-term traders who cannot tolerate sharp swings. The company pays no dividend (payout ratio 0), so returns depend entirely on capital appreciation. However, the long-term growth story is compelling: 30.5% revenue growth, a large and expanding addressable market in NoSQL databases and AI-driven application development, and a fortress balance sheet with $1.01B cash. Earnings visibility is improving as the company swings to GAAP profitability, but the CEO transition adds near-term uncertainty. A suggested minimum holding period of 2-3 years allows time for the leadership transition to resolve and for Atlas growth to compound.
